Hyperfine, Inc.
HYPRNasdaqCIK 1833769HealthcareFiscal year ends Dec 31
Reports and events: 104 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0811:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-417437 |
| 2026-09-1820:07 ET | 8-K | 3.01 Delisting notice | 0001193125-26-395525 |
| 2026-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338015 |
| 2026-08-0620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337963 |
| 2026-05-2120:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-234426 |
| 2026-05-1220:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219428 |
| 2026-05-1220:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219380 |
| 2026-04-0820:10 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001193125-26-147623 |
| 2026-03-1820:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-114044 |
| 2026-03-1820:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-113996 |
| 2026-03-1820:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-113960 |
| 2026-01-1213:28 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009859 |
| 2025-12-2921:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-335370 |
| 2025-11-1321:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280212 |
| 2025-11-1321:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280181 |
| 2025-10-1620:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241438 |
| 2025-10-1520:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-240255 |
| 2025-08-1320:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108047 |
| 2025-08-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108030 |
| 2025-08-0620:01 ET | 8-K | 8.01 Other events | 0000950170-25-103970 |
| 2025-05-2321:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-125906 |
| 2025-05-1920:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-074355 |
| 2025-05-1320:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070402 |
| 2025-05-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070340 |
| 2025-05-0220:08 ET | 8-K | 3.01 Delisting notice | 0000950170-25-062762 |
| 2025-04-0720:05 ET | DEF 14A | Proxy statementPeriod 2025-05-19 | 0001193125-25-074640 |
| 2025-03-1720:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040281 |
| 2025-03-1720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040251 |
| 2025-02-1121:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024326 |
| 2025-02-1113:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-023996 |
| 2025-01-2914:00 ET | 8-K | 2.05 Exit or disposal costs | 0000950170-25-010230 |
| 2024-11-1222:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125624 |
| 2024-11-1221:15 ET | 8-K | 2.02 Results of operations | 0000950170-24-125433 |
| 2024-08-0920:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094720 |
| 2024-08-0820:11 ET | 8-K | 2.02 Results of operations | 0000950170-24-093965 |
| 2024-07-2420:15 ET | 8-K | 8.01 Other events | 0000950170-24-086057 |
| 2024-06-1220:04 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-072416 |
| 2024-05-3120:06 ET | 8-K | 3.01 Delisting notice | 0000950170-24-067303 |
| 2024-05-1420:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059482 |
| 2024-05-1320:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058664 |
| 2024-04-2620:10 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001193125-24-118049 |
| 2024-03-2220:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-035343 |
| 2024-03-2120:11 ET | 8-K | 2.02 Results of operations | 0000950170-24-034697 |
| 2023-11-0921:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-274593 |
| 2023-11-0921:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062066 |
| 2023-11-0921:10 ET | 8-K | 2.02 Results of operations | 0000950170-23-062049 |
| 2023-10-0320:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-051513 |
| 2023-08-1420:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042430 |
| 2023-08-1420:11 ET | 8-K | 2.02 Results of operations | 0000950170-23-042415 |
| 2023-07-1820:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-033349 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.